American College of Cardiology
500 episodes listed below
PRESS PLAY
A weekly co-hosted podcast featuring JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC and JACC Senior Consulting Editor Carolyn S.P. Lam, MBBS, PhD, giving readers context on our weekly issues. Listen in as they break down the latest trends and share practical tips that are changing the way heart care works globally.
Based on 6 episodes we listened to · September 2026
JACC This Week makes cardiovascular research legible by connecting study findings to clinical judgment, technology, and health policy.
JACC This Week turns new cardiovascular research into an editor-led briefing, with Harlan Krumholz moving from study design and results to the decisions those findings might change.
Polymer valves, certification reform: if both belong in your cardiology homework, Harlan Krumholz understands the assignment.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A China-focused cardiovascular discussion connects trial design and national surveillance to a measured case for global learning.
This China-focused issue of Jack This Week uses cardiovascular science to argue for looking beyond national borders. Dr. Carolyn Lam and Dr. Harlan Kronholz move from the BLESS study, built around eight patuanjing movements and blood pressure, to a national surveillance effort…
A measured PlayNext review of ADVENT-HF, sleep-disordered breathing, and LV interpretation.
A focused PlayNext episode on sleep-disordered breathing in the ADVENT-HF population, with host Mitsuhaki Sawano speaking with paper author Shoichiro Yatsu about how breathing patterns relate to left ventricular structure and function.
A journal roundup where machine learning reinforces the old clinical habit of asking patients how they feel.
The June 17, 2025 issue summary works best when it lets the KCCQ12 analysis anchor a busy cardiovascular roundup. In outpatient heart failure care, patients with KCCQOS scores below 25 had higher adjusted risk of 90-day hospitalization and cumulative mortality, and noncompletion…
A careful device-trial story about why good-looking registry data can still miss a failure mode.
ACURATE Neo 2 Under-Expansion treats a valve trial as a test of how procedural success should be judged. It moves from the Accurate platform to the IDE trial, then into a post-hoc analysis that asks why a system with strong registry results still drew concern when it was put…
A dense but useful cardiovascular issue that turns trial and registry data into practical judgment.
This issue takes a measured pass across cardiovascular medicine, moving from physician certification and hidden blood cell mutations to LVAD anticoagulation, after-TAVI therapy, prosthetic valve imaging, post-infarct inflammation, and drug-coated balloons.
A brisk cardiology issue linking valve trials, central adiposity, and hospital ownership.
Jack This Week moves from valve trials to obesity-related heart failure to private equity ownership in hospitals, and that range gives the issue its shape.
A careful look at how outcomes and care questions shift once the patients are already very old.
Aging sits at the center of this conversation. It follows patients in their 70s, 80s, and 90s in Japan, and it treats the oldest patients as a real clinical issue, not a side note.
A thoughtful handoff about gratitude, editorial judgment, and the editor as an educator who helps readers sort what matters.
This conversation reads as a courteous handoff, with gratitude for Valentin Fuster at the center and a clear sense of what editorial leadership asks of a journal. Harlan Krumholz and Fuster treat the editor as more than a conveyor of findings.
Critical care evidence, carefully talked through.
Oncology evidence translated into clinical decisions.
Clinical research, reduced to its practical signal.
This episode discusses a special issue of JACC focused on cardiovascular statistics, exploring why progress in cardiovascular health has stalled despite medical breakthroughs and new therapies.
This episode of JACC This Week reviews key studies from the journal's latest issue, including a trial favoring conduction system pacing over right ventricular pacing, research on HEPA filters lowering blood pressure, long-term outcomes of FFR vs IVUS guided PCI, a review on heart failure therapy implementation, and data on health equity disparities in cardiovascular care.
This episode of JACC This Week reviews recent cardiovascular studies, including a counterintuitive ECMO physiology finding, nuanced angina trajectories, statin benefits in type 1 diabetes, and discussions on editorial independence and gold-standard science.
Harlan Krumholz interviews Valentin Fuster on the transition of the JACC podcast, expressing gratitude for Fuster's year of hosting after stepping down as editor-in-chief.
This episode of JACC This Week focuses on a mini-issue about amyloid heart disease, covering biomarkers, structural insights, and therapeutic strategies, including discussions on high drug costs, negative trial results for vasovagal syncope, and DOACs vs warfarin in frail elderly patients.
This episode discusses research on out-of-hospital cardiac arrest in septuagenarians, octogenarians, and nonagenarians in Japan, focusing on survival trends and data from national registries.
This episode of JACC This Week explores recent cardiovascular intervention research, covering how risk factors affect plaque vulnerability, the potential of virtual flow reserve post-PCI, safety concerns with thin-strut stents, long-term outcomes of complete revascularization, and trends in outpatient PCI.
This episode discusses JACC's special issue dedicated entirely to Dr.
This episode analyzes a study exploring whether preventing in-hospital cardiac arrests, rather than just improving resuscitation, could be the key to better patient outcomes, highlighting research that links registry data with Medicare claims to measure incidence and survival rates.
This episode explores the evolving question of how low to treat blood pressure in cardiovascular medicine, examining evidence for intensive control while also reflecting on meaningful end-of-life care conversations in medical practice.
This episode discusses the limitations of current cardiovascular risk prediction models that fail to account for geographic variations in disease risk, proposing the need for location-specific calibration factors.
This episode discusses the shift in cardiovascular medicine from uniform approaches to personalized strategies, highlighting research on hypertrophic cardiomyopathy thresholds and genetic variant-specific arterial event risks.
This episode analyzes a large U.S.
This episode of JACC This Week provides a guided briefing on the latest medical research, focusing on a study linking wildfire smoke exposure to increased heart failure risk using Medicare data.
This episode examines a study validating the American Heart Association's PREVENT cardiovascular risk equations across four major U.S.
This episode discusses a study examining whether middle-aged athletes with high post-exercise cardiac troponin levels are more likely to have hidden coronary artery disease than their peers.
This episode discusses a JACC journal paper characterizing arterial aneurysms in Loeys-Dietz Syndrome, focusing on the prevalence and clinical outcomes of extraaortic arterial involvement.
This episode discusses a study on long-term survival and patient-reported outcomes following staged reconstructive surgery for Hypoplastic Left Heart Syndrome, a high-risk congenital heart condition in newborns.
This episode discusses the 2025 AHA-ACC Multisociety High Blood Pressure Guideline and its implications for medical practice, policy, and research through expert commentaries.
This episode discusses recent research on cardiometabolic health, including the impact of COVID-19 on healthcare utilization and mortality rates among Medicare beneficiaries, and explores prevention strategies and lipid management in young adults.
This episode discusses a medical journal issue focusing on heart failure, including research on Chagas disease, genetic bases of cardiomyopathies, and broader topics like racial disparities and universal health systems.
This episode discusses the transformative advancements in hypertrophic cardiomyopathy treatment, focusing on the MAPLE-HCM trial, myosin inhibitors, and what clinical improvement truly means in this rapidly evolving field of cardiology.
This episode discusses a special issue of JACC focusing on women's cardiovascular health, emphasizing the need to move beyond treating women as a subgroup and instead redesign cardiovascular science, care, and training around them from the outset.
This episode discusses the November 18, 2025 issue of JACC focusing on adiposity and heart failure, while exploring the editor's philosophy of partnership with authors to advance cardiovascular science.
This episode of JACC This Week discusses clonal hematopoiesis, an aging-related blood condition linked to increased cardiovascular risk, based on an exploratory study from the LIDOCO2 trial examining colchicine's effects.
This editor's page discusses the evolving landscape of cardiac electrophysiology, highlighting recent studies on atrial fibrillation treatment strategies and device therapy evaluations.
This episode explores how traditional cardiovascular risk factors like diabetes and smoking correlate with vulnerable plaque features in coronary arteries, using optical coherence tomography data from over 1,500 acute coronary syndrome patients.
The editor-in-chief reflects on his first year, emphasizing that listening to authors, reviewers, readers, and the broader medical community reveals a shared desire for connection, trustworthy information, and maintaining patient-centered values in medicine.
This episode discusses a research study on the prevalence and predictors of neurocognitive dysfunction in young adults with moderate to severe congenital heart disease, highlighting common cognitive challenges despite outward physical health.
This episode reviews recent electrophysiology studies from JACC, focusing on left atrial appendage closure devices for stroke prevention in atrial fibrillation patients and comparing catheter ablation to lifestyle modification for arrhythmia management.
This episode discusses the growing importance of amyloidosis in cardiology, highlighting recent scientific advances, diagnostic challenges, treatment options, and access issues in clinical practice.
Two cardiology journal editors discuss the reboot of their podcast, focusing on a new issue themed on valve disease and their editorial approach to engaging the global cardiology community.
This episode discusses a major global study on cardiovascular disease burden and risk factors from 1990 to 2023, highlighting research collaboration and implications for public health.
This episode discusses the integration of artificial intelligence in medicine, focusing on ethical guidelines, genetic risk assessment, and advancements in cardiovascular treatments.
This episode discusses a mini-spotlight issue on adult congenital heart disease (ACHD) guidelines, exploring how advances in cardiology have transformed fatal conditions into chronic diseases requiring specialized management.
This episode discusses the latest advancements and challenges in interventional cardiology, highlighting research from a JACC focus issue on topics like plaque vulnerability and drug-eluting stents.
This episode of JACC This Week focuses on cardiovascular disease prevention, covering studies on polypill projections, global syndemic risk factors, validation of PREVENT risk equations, inclisiran monotherapy, and rising CKM syndrome prevalence.
Valentin Fuster summarizes the June 24, 2025 issue of JACC, covering four original papers on topics like arterial aneurysms in Loeys-Dietz syndrome, exercise-induced troponin elevations in athletes, and long-term outcomes for hypoplastic left heart syndrome surgery, plus a state-of-the-art review on heart failure with improved ejection fraction.
This episode features Professor Matsushita discussing his research on coronary artery calcium in elderly participants from the ARIC study, highlighting the significance of zero calcium findings and 30-year risk factor tracking.
This episode of JACC This Week covers emerging frontiers in cardiology, including reforming physician certification, the role of clonal hematopoiesis in heart disease, advances in LVAD technology, and new approaches like drug-coated balloons and inflammation targeting after heart attacks.
This episode of JACC This Week covers recent cardiovascular research, including AI standards for submissions, terzepatide's effects in heart failure with preserved ejection fraction, racial disparities in hospitalization ages, genetic variants in atrial fibrillation, and the burden of heart failure in Japan's elderly population.
This episode of JACC This Week covers key cardiovascular research, including a post-hoc analysis of the ACCURATE NEO2 valve trial linking under-expansion to worse outcomes, insights on obesity-related heart failure and tirzepatide, a study on private equity ownership's impact on heart failure care, and a special communication on multivalvular disease management.
This episode explores the history and current challenges of women's cardiovascular health, emphasizing the need to redesign medical systems beyond mere inclusion to better serve both women and men.
This episode analyzes the failure of the ACURATE neo2 trans-catheter aortic valve in a randomized trial, exploring a post-hoc study that links under-expansion to adverse outcomes and discusses broader implications for device evaluation and patient care.
Harlan Krumholz discusses JACC's latest issue, covering computable quality for healthcare improvement, community screening for cardiovascular risks, AI in echocardiography, anticoagulation in pulmonary arterial hypertension, and a debate on TAVR for low-risk patients with evolving evidence.
This episode of JACC This Week covers key cardiovascular research, including clinician roles in device safety, evidence for abbreviated DAPT therapy reducing bleeding events, drug-coated balloons for complex restenosis, a first-in-human polymer mitral valve study, and obesity management guidance for cardiologists.
This episode of JACC This Week discusses AI's role in scientific writing, emphasizing accountability, and reviews key studies: nearly all cardiovascular events have preceding risk factors, percutaneous debulking shows promise for device infections, Obacetrapib revives CETP inhibition hopes, and combination therapy accelerates kidney protection in diabetes.
This episode discusses a study on differences in arterial events among vascular Ehlers-Danlos, Loeys-Dietz, and Marfan syndromes, using data from the Montalcino Aortic Consortium.
This episode of JACC This Week reviews recent research on heart failure, covering dual therapy insights from the Salgaldi-PEF trial, risks of therapy withdrawal in improved ejection fraction patients, finerenone discontinuation effects, sex differences in genetic cardiomyopathy, and updates on ICD use and digital tools.
Hosts discuss the role of medical conferences and listener feedback on the JACC journal podcast.
Hosts discuss the latest issue of JACC focused on cardiovascular research from China, emphasizing global collaboration and scientific progress.
["Mitsuhaki Sawano interviews Shoichiro Yatsu on Jack Baran about an ADVENT-HF analysis of sleep-disordered breathing in heart failure.", "Yatsu describes a 49-site randomized trial in nine countries, published in The Lancet Respiratory Medicine in December 2023, enrolling patients with LVEF at or below 45% and sleep-apnea criteria.", "He contrasts ADVENT-HF with the earlier CERB-HF signal, and says COVID-19 plus a June 2021 device recall complicated enrollment and follow-up.", "The paper found no left-ventricular structure or function change after six months, but ASV improved Minnesota Living Heart Failure Questionnaire scores, Epworth Sleepiness Scale scores, NYHA class, and sleep-quality measures."]
This episode summarizes original research and state-of-the-art reviews from the June 17, 2025 issue of JACC, covering cardiovascular risk prediction, heart failure outcomes, pulmonary angioplasty, and factor XI inhibition.
This episode discusses a study on long-acting Factor XI inhibition and periprocedural bleeding in atrial fibrillation patients.
Valentin Fuster summarizes JACC’s June 10, 2025 guideline spotlight issue on the 2025 ACC/AHA recommendations for acute coronary syndromes.
Valentin Fuster reviews the June 3, 2025 JACC lipid issue, focusing on lipoprotein A and the oral PCSK9 inhibitor AZD-0780.
A state-of-the-art review of anthracycline cardiotoxicity in adult cancer patients, covering mechanisms, risk factors, and cardioprotective strategies.
This episode summarizes the latest issue of JACC focused on electrophysiology, covering original research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive ablation in tetralogy of Fallot.
This episode summarizes the April 29, 2025 issue of JACC, focusing on cardiogenic shock, including a clinical trial on intra-aortic balloon support, new clinical guidelines, and a machine learning analysis from the ECLS Shock Trial.
This episode summarizes the April 29, 2025 issue of JACC, focusing on cardiogenic shock, including a clinical trial on intra-aortic balloon support, a consensus statement, and a machine learning sub-analysis.
This episode summarizes the April 29, 2025 issue of JACC, focusing on cardiogenic shock with original research, clinical guidelines, and a machine learning sub-analysis.